Overview / Abstract: |
This CME-accredited CME Snapshotâ„¢ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholesterol (LDL-C) levels using nonstatin lipid-lowering medications, including inhibitors of the enzyme protein convertase subtilisin/kexin type 9 (PCSK9). |
Expiration |
Apr 04, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Seminar, Webinar / Webcast / Video |
Credits / Hours |
0.50 |
Accreditation |
ACCME, CE |
Presenters / Authors / Faculty |
Deepak L. Bhatt, MD, MPH; Christopher P. Cannon, MD |
Sponsors / Supporters / Grant Providers |
These activities have been supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals and jointly provided by the Elsevier Office of Continuing Medical Education and Integritas Communications. |
Keywords / Search Terms |
Integritas Communications, CME, CE, ACCME, Credit, Dyslipidemia, Free CE, Free CME, Continuing Medical Education, Continuing Education, video, webcast, Bhatt, Cannon, CME Snapshot, lipoprotein cholesterol, LDL-C, protein convertase subtilisin/kexin type 9, PCSK9 |